AXIC A — aXichem AB (publ) Share News
0.000.00%
- SEK111.41m
- SEK107.44m
- SEK18.45m
Brief: Axichem Obtains New Patent In Brazil
Brief: aXichem Takes Up Convertible Loan Of SEK 20 Million
Brief: aXichem Obtains Another Order For Axivite
Brief: Axichem Q4 Operating Loss Widens To SEK 5.0 Million
Brief: aXichem Signs Business Collaboration Agreement With GCV Life
Brief: Axichem Updates Company's Goals For 2022
Brief: aXichem Obtains New Order For Axivite From Its US Distributor Berg Nutrition
Brief: aXichem Signs Agreement With Caldic Denmark
Brief: Axichem Q3 Net Sales At SEK 3.5 Million
Brief: Axichem Secures Production Capacity For Phenylcapsaicin
Brief: Axichem's Polish Distributor To Develop Axivite-Based Product
Brief: aXichem Gets New US Patent For Phenylcapsaicin As Ingredient In Poultry Feed
Brief: aXichem Delivers aXiphen-Feed To Distributor CHR. Olesen
Brief: aXichem Q2 Operating Loss Widens To SEK 3.9 Mln
Brief: Axichem - Is Applying For Patent For Phenylcapsaicin For Treatment Of Ideopathic Pulmonary Fibrosis
Brief: aXichem Signs Agreement For Marketing And Distribution Of Axivite In Italy
Brief: aXichem Signs Agreement With Spanish Company Pharmafoods
Brief: aXichem Natural Analogue Capsaicin Shows Significant Effect In New Clinical Trial
Brief: Axichem Q1 Operating Loss Widens To SEK 3.2 Mln